Want to know more about how collaboration and better risk assessment can help inform strategy and address challenges in early discovery? Our early discovery webinar series combines the knowledge of Abzena team members in various fields with talks from experts across the business.

Optimal Formulation Development

Formulation is a critical part of the drug development process and encompasses a wide range of activities including developability and buffer screening, as well as dosage studies and compatibility with the required storage container or administration device. Early investment into the optimal form of the drug candidate as part of a developability program pays dividends […]

Watch the Webinar

Efficient Biological Drug Development Workflows: Lead Candidate to Drug Substance

Discover how to support a faster critical development path and reduce timelines to manufacture of drug substance and product for clinical trials with strategies for maximizing the overlap of activities during process development and manufacture, keeping DC selection options open for longer to generate better data with the aim of minimising risk. The discussion explores […]

Watch the Webinar

Early Therapeutic Antibody Development: Addressing the Challenges to Expedite a CMC Program.

Learn how de-risk early-stage CMC and delivery of clinical trials material by addressing the challenges faced when therapeutic antibodies show less-than-ideal properties, from early development through to downstream manufacturing to pre-clinical and clinical studies.

Watch the Webinar

Addressing Immunogenicity Challenges to Select the Best Drug Development Candidate.

De-risk and accelerate your programs by understanding some of the approaches to therapeutic protein immunogenicity risk assessment and how this helps you make better-informed candidate selection.

Watch the Webinar

The Strategy Behind Your Journey to GMP with Emphasis on Linker Payload Development.

Develop lower risk strategies with our insights into the key considerations you need to factor in when conjugating your linker payload to its antibody in our review of the pros and cons of semi-synthetic and synthetic linker payloads.

Watch the Webinar

Collaborative Approaches Needed to Effectively Speed Up and Streamline Development.

Listen to the strategies used to effectively speed up and streamline development including insight into the collaborative approaches needed between functional areas and the compromises required.

Watch the Webinar

Pre-formulation: De-risking Development Programs to Ensure a Successful IND Filing.

Discover how to streamline your drug programs by better-utilising pre-formulation programmes and see how Abzena approaches pre-formulation to identify fundamental drug properties.

Watch the Webinar